• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
      • Open API
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Modular Synthesis of Four-membered Carbo- and Heterocycles

Modular Synthesis of Four-membered Carbo- and Heterocycles

Bernhard Wölfl (ORCID: 0000-0001-6736-5977)
  • Grant DOI 10.55776/J4393
  • Funding program Erwin Schrödinger
  • Status ended
  • Start January 16, 2020
  • End December 15, 2022
  • Funding amount € 120,852
  • Project website

Disciplines

Chemistry (100%)

Keywords

    Organozinc, 1,2-metalate rearrangement, Azetidines, Trisubstituted Cyclobutanes, Strain-Release, Bicyclo[1.1.0]Butyl Zincate Complexes

Abstract Final report

One of the main aspects of the modern pharmaceutical industry is the development of new medicines for the treatment of disease and improvement of overall quality of life. Herein organic chemistry is of profound importance, as it provides the necessary means to make new drugs. The development of new chemical reactions enables more and more complex molecules to be made, allowing for the incorporation of structural features into these compounds which were previously difficult to introduce. The method which will be investigated in this project aims to build molecules that contain a so-called cyclobutane. These structures consist of four carbon atoms where each carbon forms a chemical bond to two other carbons respectively, resulting in a molecule that is shaped like a square, in which each corner represents one carbon atom. As carbon can make chemical bonds to four other atoms, each carbon at the corner of this square is connected to two other atoms, usually hydrogen or other carbons that can be a part of a larger organic molecule, which can be used as a drug for example. The presence of a cyclobutane structure in drug molecules can be beneficial as the unusual structure makes them less recognizable to our metabolic enzymes, which break down drugs. As a result the drug can last longer in the body without being degraded, giving it more time to do its job. Unfortunately, the introduction of cyclobutanes to organic molecules is often difficult and there is only a limited set of methods to accomplish this. Our aim is to develop a new method to generate cyclobutanes from compounds that are called bicyclobutanes. These bicyclobutanes can be readily made from simple and cheap substances. It is planned to find the best way to add additional molecules to the bicyclobutane, turning it into a cyclobutane. Once this method is established it will grant efficient access to a broad variety of complex molecules containing cyclobutanes. As it is known that the incorporation of cyclobutanes into drug molecules can lead to improved properties, this project holds considerable promise for the development of drugs that could greatly benefit mankind.

One of the main aspects of the modern pharmaceutical industry is the development of new medicines for the treatment of disease and improvement of overall quality of life. Herein organic chemistry is of profound importance, as it provides the necessary means to make new drugs. The development of new chemical reactions enables more and more complex molecules to be made, allowing for the incorporation of structural features into these compounds which were previously difficult to introduce. The method which will be investigated in this project aims to build molecules that contain a so-called cyclobutane. These structures consist of four carbon atoms where each carbon forms a chemical bond to two other carbons respectively, resulting in a molecule that is shaped like a square, in which each corner represents one carbon atom. As carbon can make chemical bonds to four other atoms, each carbon at the corner of this square is connected to two other atoms, usually hydrogen or other carbons that can be a part of a larger organic molecule, which can be used as a drug for example. The presence of a cyclobutane structure in drug molecules can be beneficial as the unusual structure makes them less recognizable to our metabolic enzymes, which break down drugs. As a result, the drug can last longer in the body without being degraded, giving it more time to do its job. Unfortunately, the introduction of cyclobutanes to organic molecules is often difficult and there is only a limited set of methods to accomplish this. Consequently, we investigated reactions that would enable us to generate new types of cyclobutanes. In one of these reactions spirocyclic cyclobutanes were generated. These were molecules in which a carbon atom of the cyclobutane ring is linked to yet another carbon atom and an oxygen atom or nitrogen atom, these two additional atoms also being chemically bonded to one another. During this project, the synthesis of these compounds was optimized and a wide variety of simple and complex spirocyclic cyclobutanes were generated. These cyclobutanes can be efficiently integrated into complex molecules by other known simple methods. So-called bicyclobutane, which can be produced from simple and cheap chemicals in an uncomplicated manner, served as the starting material. As it is known that the incorporation of cyclobutanes into drug molecules can lead to improved properties, an innovative method was developed for the development of novel drugs that could greatly benefit mankind.

Research institution(s)
  • Technische Universität Graz - 100%
  • University of Bristol - 100%

Research Output

  • 2 Publications
  • 2 Datasets & models
Publications
  • 2023
    Title Strain-Release Driven Epoxidation and Aziridination of Bicyclo[1.1.0]butanes via Palladium Catalyzed s-Bond Nucleopalladation
    DOI 10.1002/anie.202217064
    Type Journal Article
    Author Wölfl B
    Journal Angewandte Chemie International Edition
    Link Publication
  • 2023
    Title Strain-Release Driven Epoxidation and Aziridination of Bicyclo[1.1.0]butanes via Palladium Catalyzed s-Bond Nucleopalladation
    DOI 10.1002/ange.202217064
    Type Journal Article
    Author Wölfl B
    Journal Angewandte Chemie
    Link Publication
Datasets & models
  • 2023 Link
    Title CCDC 2115071: Experimental Crystal Structure Determination
    DOI 10.5517/ccdc.csd.cc28zx39
    Type Database/Collection of data
    Public Access
    Link Link
  • 2023 Link
    Title CCDC 2115072: Experimental Crystal Structure Determination
    DOI 10.5517/ccdc.csd.cc28zx4b
    Type Database/Collection of data
    Public Access
    Link Link

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF